Daiwa Securities Group Inc. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5
-28.6%
2,7280.0%0.00%
Q2 2023$7
+40.0%
2,7280.0%0.00%
Q1 2023$5
+66.7%
2,728
+236.8%
0.00%
Q4 2022$3810
+142.5%
0.00%
Q3 2022$03340.0%0.00%
Q2 2022$0
-100.0%
3340.0%0.00%
Q1 2022$1,0000.0%3340.0%0.00%
Q4 2021$1,000
-50.0%
3340.0%0.00%
Q3 2021$2,000
+100.0%
334
+115.5%
0.00%
Q2 2021$1,0000.0%1550.0%0.00%
Q1 2021$1,0000.0%1550.0%0.00%
Q4 2020$1,0001550.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders